| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/24/2008 | EP2004222A2 Vaccine |
| 12/24/2008 | EP2004221A2 Anti-tumor cell antigen antibody therapeutics |
| 12/24/2008 | EP2004220A2 Methods and compositions for vaccination of poultry |
| 12/24/2008 | EP2004219A2 Reagents and methods for cancer treatment and prevention |
| 12/24/2008 | EP2004218A2 Her-2/neu multi-peptide vaccine |
| 12/24/2008 | EP2004217A1 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 12/24/2008 | EP1549340B1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 12/24/2008 | EP1519953B1 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s) |
| 12/24/2008 | EP1368061B1 Fusion cells and cytokine compositions for treatment of disease |
| 12/24/2008 | EP1328291B1 Viruses targeted to hypoxic cells and tissues |
| 12/24/2008 | EP1299523B1 Method for the modification of biological cells |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | EP1097212B1 Anthrax vaccine |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | EP0909277B2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/24/2008 | DE102007028687A1 Composition for treating an autoimmune disease in an individual comprises an autologous antigen that induces an autoimmune reaction |
| 12/24/2008 | DE102007028659A1 Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen Diagnostic substance and method for the diagnosis of prostate disease |
| 12/24/2008 | CN101331151A Means and methods for the treatment of tumorous diseases |
| 12/24/2008 | CN101331150A Human monoclonal antibody human CD134 (OX40) and methods of making and using same |
| 12/24/2008 | CN101330930A Therapeutic agent for heart disease |
| 12/24/2008 | CN101330929A Inhibitor of transplanted islet dysfunction in islet transplantation |
| 12/24/2008 | CN101330928A Immunostimulatory combination for the prophylactics and treatment of hepatitis c |
| 12/24/2008 | CN101330927A Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 12/24/2008 | CN101330926A Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
| 12/24/2008 | CN101330925A Therapeutic methods for inhibiting tumor growth with D114 antagonists |
| 12/24/2008 | CN101330924A Vaccine compositions comprising a saponin adjuvant |
| 12/24/2008 | CN101330923A 治疗性疫苗 Therapeutic vaccine |
| 12/24/2008 | CN101328219A Nano liposome anti-HPV, gynecological inflammation pathogen specific compound IgY and combined preparation thereof |
| 12/24/2008 | CN101328211A Two leptospira outer membrane proteins of vaccine candidates |
| 12/24/2008 | CN101328210A HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 12/24/2008 | CN101328209A HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 12/24/2008 | CN101328208A HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 12/24/2008 | CN101327324A Method and composition for treating autoimmunity disease |
| 12/24/2008 | CN101327323A Lyophilization technique for preparing lyophilized hepatitis A attenuated live vaccine |
| 12/24/2008 | CN101327315A Use of maltose binding protein as immunopotentiator |
| 12/24/2008 | CN100445300C GLP-1 fusion protein and its preparation method and medicinal uses |
| 12/24/2008 | CN100444895C Immunomodulator for treating malignant tumor |
| 12/24/2008 | CN100444848C Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 12/24/2008 | CA2855098A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2692098A1 Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase |
| 12/24/2008 | CA2692072A1 Methods and agents for inhibiting tumor growth |
| 12/24/2008 | CA2692069A1 Modified polysaccharides for conjugate vaccines |
| 12/24/2008 | CA2691855A1 Lyophilized immunoglobulin formulations and methods of preparation |
| 12/24/2008 | CA2691357A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | CA2691322A1 Anti-cd20 therapeutic compositions and methods |
| 12/24/2008 | CA2691251A1 Preventive/remedy for cancer |
| 12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
| 12/24/2008 | CA2690668A1 Vaccines containing canine parvovirus genetic variants |
| 12/24/2008 | CA2690449A1 Synergistic treatment of cells that express epha2 and erbb2 |
| 12/24/2008 | CA2690435A1 Humanized antibodies to amyloid beta |
| 12/24/2008 | CA2690434A1 Monoclonal anti beta amyloid antibody |
| 12/24/2008 | CA2690382A1 Antibody formulations |
| 12/24/2008 | CA2690271A1 Chlamydia antigens |
| 12/24/2008 | CA2689658A1 Methods and compositions for treating mucositis |
| 12/24/2008 | CA2689521A1 Anti-igf antibodies |
| 12/24/2008 | CA2689181A1 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
| 12/23/2008 | US7468423 Homogeneous preparations of IL-28 and IL-29 |
| 12/23/2008 | US7468352 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/23/2008 | US7468350 Glue composition for lung volume reduction |
| 12/23/2008 | US7468259 Influenza vaccine |
| 12/23/2008 | US7468256 Tools for detecting Moraxella catarrhalis |
| 12/23/2008 | US7468190 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages |
| 12/23/2008 | US7468189 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 12/23/2008 | US7468188 Multi-step therapy for injured muscles |
| 12/23/2008 | US7468187 For inducing an immune response to the influenza virus in canines, veterinary medicine |
| 12/23/2008 | US7468186 Human Leukocyte Antigen-A*02-restricted cellular epitopes within the VP1 polypeptide of a human polyomavirus; vaccines |
| 12/23/2008 | US7468185 Vaccine for periodontal disease |
| 12/23/2008 | US7468184 Therapeutic agent for cachexia |
| 12/23/2008 | US7468183 using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B; preparation of the antibody using a fragment library |
| 12/23/2008 | CA2324115C A preventive or therapeutic agent for inflammatory bowel disease comprising il-6 antagonist as an active ingredient |
| 12/23/2008 | CA2285298C Complexes comprising local anesthetic and nucleic acid and method of making and using the same |
| 12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
| 12/23/2008 | CA2212750C Humanized antibodies against cd3 |
| 12/23/2008 | CA2182889C Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor |
| 12/23/2008 | CA2158822C Therapeutic agent for rheumatic disease |
| 12/23/2008 | CA2139515C Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 12/22/2008 | CA2593558A1 Vaccine against clostridium perfringens |
| 12/18/2008 | WO2008154543A2 Methods for treating juvenile idiopathic arthritis |
| 12/18/2008 | WO2008154439A1 Methods and compositions for inducing apoptosis in cancer cells |
| 12/18/2008 | WO2008154251A2 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 12/18/2008 | WO2008153997A1 Reduced-mass, long-acting dosage forms |
| 12/18/2008 | WO2008153962A2 Method of reducing tissue loss in pancreatic islet cell transplantation |
| 12/18/2008 | WO2008153926A2 Inhibitors of receptor tyrosine kinases and methods of use thereof |
| 12/18/2008 | WO2008153881A1 Novel cell-based assays for indentifying enhancers or inhibitors of t1r taste receptors (t1r2/t1r3 sweet) and umami (t1r1/t1r3 umami) taste receptors |
| 12/18/2008 | WO2008153794A1 Raccoon poxvirus expressing rabies glycoproteins |
| 12/18/2008 | WO2008153772A2 Chlamydia vaccine comprising htra polypeptides |
| 12/18/2008 | WO2008153692A2 Microrna expression profiling of cerebrospinal fluid |
| 12/18/2008 | WO2008153655A2 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis |
| 12/18/2008 | WO2008153636A1 Phospho-specific antibodies to p13k regulatory subunit and uses thereof |
| 12/18/2008 | WO2008153610A2 Use of il-23 antagonists for treatment of infection |
| 12/18/2008 | WO2008153572A1 Construction of chimera prrsv, compositions and vaccine preparations |
| 12/18/2008 | WO2008153541A1 Vaccine composition containing synthetic adjuvant |
| 12/18/2008 | WO2008153420A1 Methods of selecting host resistant animals |
| 12/18/2008 | WO2008153236A1 An attenuated influenza virus and a live vaccine comprising the same |
| 12/18/2008 | WO2008153150A1 Method for culturing cell population containing nk cells and use of the cell population |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008152822A1 Medicinal agent |
| 12/18/2008 | WO2008152655A1 Anthrax fusion proteins, compositions and uses thereof |